Choudhury P, Chen W, Hunt R C
Department of Microbiology and Immunology, University of South Carolina School of Medicine, Columbia 29208, USA.
Invest Ophthalmol Vis Sci. 1997 Apr;38(5):824-33.
In an in vitro model of the later contractile stages of proliferative vitreoretinopathy, interleukin-1 beta (IL-1 beta) and transforming growth factor-beta (TGF-beta) stimulate the contraction of collagen gels by retinal pigment epithelial (RPE) cells. This contraction occurs after a lag period and appears not to be a direct effect of the cytokines but is mediated by another factor produced in the presence of the two cytokines. The nature of this factor has been investigated.
Human RPE cells were seeded onto collagen gels in the presence of IL-1 beta and TGF-beta. After 24 hours, the conditioned medium was removed and added to new collagen gels seeded with RPE cells, and the diameter of the collagen gels was measured after various intervals. The ability of the conditioned medium to effect contraction was determined after various treatments, including size fractionation, heating, trypsin digestion, and binding to heparin-Sepharose. The involvement of platelet-derived growth factor (PDGF) as a stimulator of contraction was tested with neutralizing antibodies and by polymerase chain reaction analyses of specific mRNAs.
IL-1 beta and TGF-beta cause RPE cells to contract after a delay of up to 24 hours, whereas conditioned medium from cytokine-treated cells results in immediate contraction in a manner similar to that of serum. The factor in the conditioned medium causing immediate contraction was found to be heat-stable, trypsin-sensitive, and resistant to extremes of pH. It has a size of between 30 and 50 kDa and binds heparin. The factor in conditioned medium from cytokine-treated cells does not act in the presence of C-kinase inhibitors or cycloheximide, suggesting that signaling is mediated by way of protein kinase C and new protein synthesis. Stimulation of contraction by conditioned medium is inhibited by anti-PDGF antibodies, and contraction is stimulated by human PDGF.
Contraction in the presence of cytokines is mediated by the production of PDGF or a PDGF-like molecule. This factor could have implications in the pathogenesis of proliferative vitreoretinopathy.
在增殖性玻璃体视网膜病变后期收缩阶段的体外模型中,白细胞介素 -1β(IL -1β)和转化生长因子 -β(TGF -β)可刺激视网膜色素上皮(RPE)细胞收缩胶原凝胶。这种收缩在一段延迟期后发生,似乎并非细胞因子的直接作用,而是由在这两种细胞因子存在时产生的另一种因子介导。已对该因子的性质进行了研究。
将人RPE细胞接种到含有IL -1β和TGF -β的胶原凝胶上。24小时后,去除条件培养基并添加到接种有RPE细胞的新胶原凝胶中,在不同时间间隔后测量胶原凝胶的直径。在进行各种处理后,包括大小分级分离、加热、胰蛋白酶消化以及与肝素 - 琼脂糖结合,测定条件培养基引起收缩的能力。用中和抗体以及通过特异性mRNA的聚合酶链反应分析来检测血小板衍生生长因子(PDGF)作为收缩刺激因子的参与情况。
IL -1β和TGF -β导致RPE细胞在长达24小时的延迟后收缩,而来自细胞因子处理细胞的条件培养基会以类似于血清的方式导致立即收缩。发现条件培养基中引起立即收缩的因子对热稳定、对胰蛋白酶敏感且耐极端pH值。它的大小在30至50 kDa之间且结合肝素。来自细胞因子处理细胞的条件培养基中的因子在存在C -激酶抑制剂或环己酰亚胺时不起作用,这表明信号传导是通过蛋白激酶C和新的蛋白质合成介导的。条件培养基对收缩的刺激被抗PDGF抗体抑制,而人PDGF可刺激收缩。
细胞因子存在时的收缩是由PDGF或一种PDGF样分子的产生介导的。该因子可能在增殖性玻璃体视网膜病变的发病机制中具有重要意义。